Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report

Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2024-12, Vol.51 (12), p.1702-1706
Hauptverfasser: Bueno‐Molina, Rocío C., Hernández‐Rodríguez, Juan‐Carlos, Zulueta‐Dorado, Teresa, Pereyra‐Rodriguez, Jose‐Juan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1706
container_issue 12
container_start_page 1702
container_title Journal of dermatology
container_volume 51
creator Bueno‐Molina, Rocío C.
Hernández‐Rodríguez, Juan‐Carlos
Zulueta‐Dorado, Teresa
Pereyra‐Rodriguez, Jose‐Juan
description Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its low prevalence and varied clinical manifestations. Here, we present the case of a 49‐year‐old Spanish male with severe hidradenitis suppurativa and pyoderma gangrenosum with a heterozygous variant (p.E244K) in the MEFV gene, consistent with PAAND syndrome. This variant has only been documented in one other case with notable similarities. Both patients share Spanish ancestry and present a severe form of hidradenitis suppurativa. Treatment of the disorder presents challenges due to its variable response to standard therapies. Anti‐interleukin‐1 agents, such as anakinra or anti‐tumor necrosis factor (TNF)‐α are the therapeutic approaches supported by the most substantial evidence. Our findings highlight the importance of genetic evaluation of MEFV mutations in individuals with neutrophilic dermatosis and systemic symptoms.
doi_str_mv 10.1111/1346-8138.17390
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3085690022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3085690022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2550-e5cb4a02aab0aec523bc070432aedadcf3a26c457a9248daabc5e9827950a9cd3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EoqUws6FILCxp_dkkbFUpX6pUBpitq-OqrpK42ImqbvwEfiO_BJeUDix4Ocn33Ku7B6FLgvskvAFhfBinhKV9krAMH6Hu4ecYdTFLRUw5TjrozPsVxjQTBJ-iTkATmnLWRbOXrTPV18cneG-VgVrnETS1NdWigLKE2tgq2ph6GVW6qZ1dL01hVJRrF3rWG38bjSIFXkdOr62rz9HJAgqvL_a1h97uJ6_jx3g6e3gaj6axokLgWAs154ApwByDVoKyucIJ5oyCziFXCwZ0qLhIIKM8zQOmhM5SmmQCQ6Zy1kM3be7a2fdG-1qWxitdFFBp23jJcCqGWbiYBvT6D7qyjavCdpIRToYp5okI1KCllLPeO72Qa2dKcFtJsNy5ljuzcmdW_rgOE1f73GZe6vzA_8oNgGiBjSn09r88-Xw3aYO_AeYpikw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3141680475</pqid></control><display><type>article</type><title>Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Bueno‐Molina, Rocío C. ; Hernández‐Rodríguez, Juan‐Carlos ; Zulueta‐Dorado, Teresa ; Pereyra‐Rodriguez, Jose‐Juan</creator><creatorcontrib>Bueno‐Molina, Rocío C. ; Hernández‐Rodríguez, Juan‐Carlos ; Zulueta‐Dorado, Teresa ; Pereyra‐Rodriguez, Jose‐Juan</creatorcontrib><description>Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its low prevalence and varied clinical manifestations. Here, we present the case of a 49‐year‐old Spanish male with severe hidradenitis suppurativa and pyoderma gangrenosum with a heterozygous variant (p.E244K) in the MEFV gene, consistent with PAAND syndrome. This variant has only been documented in one other case with notable similarities. Both patients share Spanish ancestry and present a severe form of hidradenitis suppurativa. Treatment of the disorder presents challenges due to its variable response to standard therapies. Anti‐interleukin‐1 agents, such as anakinra or anti‐tumor necrosis factor (TNF)‐α are the therapeutic approaches supported by the most substantial evidence. Our findings highlight the importance of genetic evaluation of MEFV mutations in individuals with neutrophilic dermatosis and systemic symptoms.</description><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.17390</identifier><identifier>PMID: 39072843</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>anakinra ; Arthralgia ; autoinflammatory disease ; genetic ; Hereditary Autoinflammatory Diseases - diagnosis ; Hereditary Autoinflammatory Diseases - drug therapy ; Hereditary Autoinflammatory Diseases - genetics ; Hereditary Autoinflammatory Diseases - immunology ; Hidradenitis Suppurativa - diagnosis ; Hidradenitis Suppurativa - drug therapy ; Hidradenitis Suppurativa - genetics ; Hidradenitis Suppurativa - immunology ; Hidradenitis Suppurativa - pathology ; Humans ; infliximab ; Interleukin 1 receptor antagonist ; Interleukin 1 Receptor Antagonist Protein - therapeutic use ; Leukocytes (neutrophilic) ; Male ; Middle Aged ; Mutation ; Neutrophils - immunology ; Neutrophils - pathology ; Pyoderma ; Pyoderma gangrenosum ; Pyoderma Gangrenosum - diagnosis ; Pyoderma Gangrenosum - drug therapy ; Pyoderma Gangrenosum - genetics ; Pyoderma Gangrenosum - pathology ; Pyrin - genetics ; Pyrin protein ; Skin - pathology ; Skin diseases ; Sweet Syndrome - diagnosis ; Sweet Syndrome - drug therapy ; Sweet Syndrome - genetics ; Sweet Syndrome - immunology ; Sweet Syndrome - pathology ; Tumor necrosis factor-TNF</subject><ispartof>Journal of dermatology, 2024-12, Vol.51 (12), p.1702-1706</ispartof><rights>2024 Japanese Dermatological Association.</rights><rights>Copyright © 2024 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2550-e5cb4a02aab0aec523bc070432aedadcf3a26c457a9248daabc5e9827950a9cd3</cites><orcidid>0000-0001-6843-5877 ; 0000-0003-2525-4069 ; 0009-0004-0601-0995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.17390$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.17390$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39072843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bueno‐Molina, Rocío C.</creatorcontrib><creatorcontrib>Hernández‐Rodríguez, Juan‐Carlos</creatorcontrib><creatorcontrib>Zulueta‐Dorado, Teresa</creatorcontrib><creatorcontrib>Pereyra‐Rodriguez, Jose‐Juan</creatorcontrib><title>Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its low prevalence and varied clinical manifestations. Here, we present the case of a 49‐year‐old Spanish male with severe hidradenitis suppurativa and pyoderma gangrenosum with a heterozygous variant (p.E244K) in the MEFV gene, consistent with PAAND syndrome. This variant has only been documented in one other case with notable similarities. Both patients share Spanish ancestry and present a severe form of hidradenitis suppurativa. Treatment of the disorder presents challenges due to its variable response to standard therapies. Anti‐interleukin‐1 agents, such as anakinra or anti‐tumor necrosis factor (TNF)‐α are the therapeutic approaches supported by the most substantial evidence. Our findings highlight the importance of genetic evaluation of MEFV mutations in individuals with neutrophilic dermatosis and systemic symptoms.</description><subject>anakinra</subject><subject>Arthralgia</subject><subject>autoinflammatory disease</subject><subject>genetic</subject><subject>Hereditary Autoinflammatory Diseases - diagnosis</subject><subject>Hereditary Autoinflammatory Diseases - drug therapy</subject><subject>Hereditary Autoinflammatory Diseases - genetics</subject><subject>Hereditary Autoinflammatory Diseases - immunology</subject><subject>Hidradenitis Suppurativa - diagnosis</subject><subject>Hidradenitis Suppurativa - drug therapy</subject><subject>Hidradenitis Suppurativa - genetics</subject><subject>Hidradenitis Suppurativa - immunology</subject><subject>Hidradenitis Suppurativa - pathology</subject><subject>Humans</subject><subject>infliximab</subject><subject>Interleukin 1 receptor antagonist</subject><subject>Interleukin 1 Receptor Antagonist Protein - therapeutic use</subject><subject>Leukocytes (neutrophilic)</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neutrophils - immunology</subject><subject>Neutrophils - pathology</subject><subject>Pyoderma</subject><subject>Pyoderma gangrenosum</subject><subject>Pyoderma Gangrenosum - diagnosis</subject><subject>Pyoderma Gangrenosum - drug therapy</subject><subject>Pyoderma Gangrenosum - genetics</subject><subject>Pyoderma Gangrenosum - pathology</subject><subject>Pyrin - genetics</subject><subject>Pyrin protein</subject><subject>Skin - pathology</subject><subject>Skin diseases</subject><subject>Sweet Syndrome - diagnosis</subject><subject>Sweet Syndrome - drug therapy</subject><subject>Sweet Syndrome - genetics</subject><subject>Sweet Syndrome - immunology</subject><subject>Sweet Syndrome - pathology</subject><subject>Tumor necrosis factor-TNF</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQhi0EoqUws6FILCxp_dkkbFUpX6pUBpitq-OqrpK42ImqbvwEfiO_BJeUDix4Ocn33Ku7B6FLgvskvAFhfBinhKV9krAMH6Hu4ecYdTFLRUw5TjrozPsVxjQTBJ-iTkATmnLWRbOXrTPV18cneG-VgVrnETS1NdWigLKE2tgq2ph6GVW6qZ1dL01hVJRrF3rWG38bjSIFXkdOr62rz9HJAgqvL_a1h97uJ6_jx3g6e3gaj6axokLgWAs154ApwByDVoKyucIJ5oyCziFXCwZ0qLhIIKM8zQOmhM5SmmQCQ6Zy1kM3be7a2fdG-1qWxitdFFBp23jJcCqGWbiYBvT6D7qyjavCdpIRToYp5okI1KCllLPeO72Qa2dKcFtJsNy5ljuzcmdW_rgOE1f73GZe6vzA_8oNgGiBjSn09r88-Xw3aYO_AeYpikw</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Bueno‐Molina, Rocío C.</creator><creator>Hernández‐Rodríguez, Juan‐Carlos</creator><creator>Zulueta‐Dorado, Teresa</creator><creator>Pereyra‐Rodriguez, Jose‐Juan</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6843-5877</orcidid><orcidid>https://orcid.org/0000-0003-2525-4069</orcidid><orcidid>https://orcid.org/0009-0004-0601-0995</orcidid></search><sort><creationdate>202412</creationdate><title>Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report</title><author>Bueno‐Molina, Rocío C. ; Hernández‐Rodríguez, Juan‐Carlos ; Zulueta‐Dorado, Teresa ; Pereyra‐Rodriguez, Jose‐Juan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2550-e5cb4a02aab0aec523bc070432aedadcf3a26c457a9248daabc5e9827950a9cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anakinra</topic><topic>Arthralgia</topic><topic>autoinflammatory disease</topic><topic>genetic</topic><topic>Hereditary Autoinflammatory Diseases - diagnosis</topic><topic>Hereditary Autoinflammatory Diseases - drug therapy</topic><topic>Hereditary Autoinflammatory Diseases - genetics</topic><topic>Hereditary Autoinflammatory Diseases - immunology</topic><topic>Hidradenitis Suppurativa - diagnosis</topic><topic>Hidradenitis Suppurativa - drug therapy</topic><topic>Hidradenitis Suppurativa - genetics</topic><topic>Hidradenitis Suppurativa - immunology</topic><topic>Hidradenitis Suppurativa - pathology</topic><topic>Humans</topic><topic>infliximab</topic><topic>Interleukin 1 receptor antagonist</topic><topic>Interleukin 1 Receptor Antagonist Protein - therapeutic use</topic><topic>Leukocytes (neutrophilic)</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neutrophils - immunology</topic><topic>Neutrophils - pathology</topic><topic>Pyoderma</topic><topic>Pyoderma gangrenosum</topic><topic>Pyoderma Gangrenosum - diagnosis</topic><topic>Pyoderma Gangrenosum - drug therapy</topic><topic>Pyoderma Gangrenosum - genetics</topic><topic>Pyoderma Gangrenosum - pathology</topic><topic>Pyrin - genetics</topic><topic>Pyrin protein</topic><topic>Skin - pathology</topic><topic>Skin diseases</topic><topic>Sweet Syndrome - diagnosis</topic><topic>Sweet Syndrome - drug therapy</topic><topic>Sweet Syndrome - genetics</topic><topic>Sweet Syndrome - immunology</topic><topic>Sweet Syndrome - pathology</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bueno‐Molina, Rocío C.</creatorcontrib><creatorcontrib>Hernández‐Rodríguez, Juan‐Carlos</creatorcontrib><creatorcontrib>Zulueta‐Dorado, Teresa</creatorcontrib><creatorcontrib>Pereyra‐Rodriguez, Jose‐Juan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bueno‐Molina, Rocío C.</au><au>Hernández‐Rodríguez, Juan‐Carlos</au><au>Zulueta‐Dorado, Teresa</au><au>Pereyra‐Rodriguez, Jose‐Juan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2024-12</date><risdate>2024</risdate><volume>51</volume><issue>12</issue><spage>1702</spage><epage>1706</epage><pages>1702-1706</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><abstract>Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its low prevalence and varied clinical manifestations. Here, we present the case of a 49‐year‐old Spanish male with severe hidradenitis suppurativa and pyoderma gangrenosum with a heterozygous variant (p.E244K) in the MEFV gene, consistent with PAAND syndrome. This variant has only been documented in one other case with notable similarities. Both patients share Spanish ancestry and present a severe form of hidradenitis suppurativa. Treatment of the disorder presents challenges due to its variable response to standard therapies. Anti‐interleukin‐1 agents, such as anakinra or anti‐tumor necrosis factor (TNF)‐α are the therapeutic approaches supported by the most substantial evidence. Our findings highlight the importance of genetic evaluation of MEFV mutations in individuals with neutrophilic dermatosis and systemic symptoms.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39072843</pmid><doi>10.1111/1346-8138.17390</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-6843-5877</orcidid><orcidid>https://orcid.org/0000-0003-2525-4069</orcidid><orcidid>https://orcid.org/0009-0004-0601-0995</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2024-12, Vol.51 (12), p.1702-1706
issn 0385-2407
1346-8138
1346-8138
language eng
recordid cdi_proquest_miscellaneous_3085690022
source MEDLINE; Access via Wiley Online Library
subjects anakinra
Arthralgia
autoinflammatory disease
genetic
Hereditary Autoinflammatory Diseases - diagnosis
Hereditary Autoinflammatory Diseases - drug therapy
Hereditary Autoinflammatory Diseases - genetics
Hereditary Autoinflammatory Diseases - immunology
Hidradenitis Suppurativa - diagnosis
Hidradenitis Suppurativa - drug therapy
Hidradenitis Suppurativa - genetics
Hidradenitis Suppurativa - immunology
Hidradenitis Suppurativa - pathology
Humans
infliximab
Interleukin 1 receptor antagonist
Interleukin 1 Receptor Antagonist Protein - therapeutic use
Leukocytes (neutrophilic)
Male
Middle Aged
Mutation
Neutrophils - immunology
Neutrophils - pathology
Pyoderma
Pyoderma gangrenosum
Pyoderma Gangrenosum - diagnosis
Pyoderma Gangrenosum - drug therapy
Pyoderma Gangrenosum - genetics
Pyoderma Gangrenosum - pathology
Pyrin - genetics
Pyrin protein
Skin - pathology
Skin diseases
Sweet Syndrome - diagnosis
Sweet Syndrome - drug therapy
Sweet Syndrome - genetics
Sweet Syndrome - immunology
Sweet Syndrome - pathology
Tumor necrosis factor-TNF
title Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T11%3A48%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pyrin%E2%80%90associated%20autoinflammation%20with%20neutrophilic%20dermatosis:%20A%20case%20report&rft.jtitle=Journal%20of%20dermatology&rft.au=Bueno%E2%80%90Molina,%20Roc%C3%ADo%20C.&rft.date=2024-12&rft.volume=51&rft.issue=12&rft.spage=1702&rft.epage=1706&rft.pages=1702-1706&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.17390&rft_dat=%3Cproquest_cross%3E3085690022%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3141680475&rft_id=info:pmid/39072843&rfr_iscdi=true